Ecuador Medical Device Compliance Calendar: Five Phases from the 2027 Effective Date to Renewal

1. Key takeaways

Anchored on the 2027-01-28 effective date, Ecuadorian compliance obligations can be consolidated into a five-phase timeline: classification preparation, submission, review response (5-day correction, 10-day payment), post-approval (30-day completion, one-year final label) and long-term holding (renewal window, vigilance, inspection cooperation).

The critical precursor sits before all five. ARCSA must issue the supporting instructions within 9 months of 2026-04-28, covering classification detail and the graded technical file requirements. Until those instructions appear, some requirements — including the precise boundary of the low-risk categories — remain without an operational reading.

The calendar is therefore built on two dates rather than one: the date the instructions are due, which governs how the file is assembled, and the effective date, which governs when the obligation begins to bite.

2. Legal basis

3. Expert insights

Insight one: every node of the five-phase timeline corresponds to a statutory deadline.

Insight two: the simplified and general routes diverge at phase four. A simplified-route approval must be completed, through a change application, with all the material required for general registration within 30 statutory periods, failing which the certificate is cancelled immediately. The general route carries no such requirement but must submit the final label within 1 year. The post-approval obligations differ, so one schedule cannot serve both routes.

Insight three: the 9-month instruction deadline in transitional provision one is the starting point for every plan. ARCSA must publish the supporting instructions within 9 months of 2026-04-28, that is before 2027-01-28, covering classification rules and the graded technical file requirements. Until then, the operational boundary for categories such as low-risk devices is not settled, and a file designed against an assumed boundary may need to be rebuilt.

Insight four: Article 17 makes the timeline a five-year loop. The certificate is valid for 5 years and is renewable for equal periods, with a window that opens 6 months before expiry and closes 90 statutory periods before expiry. Year five is not an end point; preparation for the next cycle begins in the second half of year four.

Insight five: vigilance and technical file retention run through the whole cycle. Article 70 on vigilance and Article 67 on retention of the technical file do not end when the certificate is issued, and Article 72 provides the sanction route for both. A compliance calendar should carry them as standing items with a monthly cadence, not as event-driven tasks that appear only when something goes wrong.

Insight six: the free reclassification channel is a transition-period opportunity. Transitional provision two provides that ARCSA will reclassify existing certificates on its own initiative and that holders may also request reclassification through a change application, for which no fee is charged. Companies with broad portfolios should process the classification adjustments during the transition period rather than paying for them later.

4. Practical recommendations

1. Build a Gantt chart anchored on 2027-01-28, mapping each of the five phases to an internal milestone and a named owner.
2. Set up tracking for the supporting instructions, with an internal gap analysis completed within 30 days of their publication.
3. Schedule the two routes separately: the 30-period completion for the simplified route, the one-year final label for the general route.
4. Treat vigilance and file retention as standing compliance items with a monthly review, not as event-driven tasks.
5. Process reclassification of existing products during the transition period through the free channel, to lower the later cost of compliance.

5. Verification checklist

• □ A compliance Gantt chart anchored on 2027-01-28 has been established
• □ The five phases have been assigned internal owners and milestones
• □ A mechanism for tracking the supporting instructions and analysing gaps has been established
• □ Post-approval schedules have been set separately for the simplified and general routes
• □ Vigilance and technical file retention have been set as standing compliance items
• □ Reclassification of existing products is planned for consolidation during the transition period

Regulatory information verified as of October 29, 2026

GRZAN core service lines

1. Global registration access: EU CE (MDR/IVDR), US FDA (510(k)/De Novo/PMA), UK UKCA, Australia TGA, Canada Health Canada, Brazil ANVISA and Russia RZN, together with pre-market registration pathway planning and submission execution across Latin America, Southeast Asia and the Middle East.
2. Authorized representative services: EU EC REP, UK RP, Swiss CH REP, Australian sponsor and US Agent holding and representation services, with support for neutral license-holder structures.
3. Quality system compliance: ISO 13485 establishment and maintenance, MDSAP audit preparation, GMP conformity coaching, and technical documentation (TD) drafting and remediation.
4. Clinical and evaluation support: clinical evaluation plans (CEP) and reports (CER), equivalence argumentation, PMCF planning and execution, and IVD performance evaluation.
5. Post-market compliance: vigilance and adverse event reporting, FSCA and recall execution, registration change and renewal management, and maintenance of national regulatory databases.

Why manufacturers choose GRZAN

• Local regulatory teams: target-market work is performed by locally licensed regulatory professionals, and submission dossiers are written directly in the local official language without secondary translation.
• Neutral license-holder structures: GRZAN offers holding arrangements that are not tied to any distribution channel, preventing registration certificates from being locked in by channel partners.
• Regional leverage: one technical dossier can be reused across Andean Community and Mercosur member states, spreading regional compliance costs.
• Full lifecycle support: from classification determination and pathway design through dossier preparation, license holding, customs clearance, post-market vigilance and renewal.

Contact

• GRZAN provides registration support in Ecuador for manufacturers, importers and authorized representatives.
• Email: info@grzanglobal.com
• Service inquiries: Ecuador and Andean market registration plans, license-holder structure design, official fee and timeline estimation